HEMATOLOGY

Latest News

Luspatercept Outperforms ESA in Duration of Anemia Response in MDS
Luspatercept Outperforms ESA in Duration of Anemia Response in MDS

June 24th 2025

During a live event, Thomas LeBlanc, MD, MA, discussed the outcomes of the COMMANDS trial of luspatercept in myelodysplastic syndromes.

FDA Grants Orphan Drug Designation to SENTI-202 for R/R AML
FDA Grants Orphan Drug Designation to SENTI-202 for R/R AML

June 19th 2025

Tagraxofusp Yields Deep Responses as Frontline BPDCN Therapy
Tagraxofusp Yields Deep Responses as Frontline BPDCN Therapy

June 10th 2025

ICT01 Boosts AML Remission and Survival in EVICTION Trial
ICT01 Boosts AML Remission and Survival in EVICTION Trial

June 5th 2025

Unique Diagnostic Profile for BPDCN Warrants Focus on Hematopathology
Unique Diagnostic Profile for BPDCN Warrants Focus on Hematopathology

May 28th 2025

More News